##gff-version 3
##sequence-region Q96P16 1 312
Q96P16	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000269|Ref.5;Dbxref=PMID:19413330	
Q96P16	UniProtKB	Chain	2	312	.	.	.	ID=PRO_0000311344;Note=Regulation of nuclear pre-mRNA domain-containing protein 1A	
Q96P16	UniProtKB	Domain	2	133	.	.	.	Note=CID;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00724	
Q96P16	UniProtKB	Coiled coil	244	286	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q96P16	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000269|Ref.5;Dbxref=PMID:19413330	
Q96P16	UniProtKB	Modified residue	153	153	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q96P16	UniProtKB	Modified residue	156	156	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q96P16	UniProtKB	Modified residue	285	285	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q96P16	UniProtKB	Alternative sequence	1	51	.	.	.	ID=VSP_029531;Note=In isoform 2. MSAFSEAALEKKLSELSNSQQSVQTLSLWLIHHRKHSRPIVTVWERELRKA->MRNSNWRFCQTGIYS;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334;Dbxref=PMID:14702039,PMID:15489334	
Q96P16	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_037229;Note=In a breast cancer sample%3B somatic mutation. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q96P16	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Partial loss of binding to POLR2A CTD in vitro. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24997600;Dbxref=PMID:24997600	
Q96P16	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Partial loss of binding to POLR2A CTD phosphorylated at 'Ser-2' in the heptad repeats in vitro. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24997600;Dbxref=PMID:24997600	
Q96P16	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Partial loss of binding to POLR2A CTD in vitro. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24997600;Dbxref=PMID:24997600	
Q96P16	UniProtKB	Sequence conflict	193	193	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96P16	UniProtKB	Sequence conflict	234	234	.	.	.	Note=I->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96P16	UniProtKB	Helix	6	15	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Helix	20	32	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Helix	34	36	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Helix	37	50	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Helix	53	55	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Helix	56	70	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Turn	71	73	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Helix	76	95	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Helix	98	113	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
Q96P16	UniProtKB	Helix	119	130	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4JXT	
